Aviptadil Acetate, a vasoactive intestinal peptide (VIP), is a novel direct because the discourse of common pulmonary hypertension (PAH) that was shown to have beneficial effects on hemodynamics and safety in a phase II clinical trial for PAH.
Aviptadil (INN) embodies an analog of vasoactive intestinal polypeptide (VIP) for the treatment of male erecticle dysfunction. Catalog No.: 21970491-1. Aviptadil inwards combination with phentolamine and sexual stimulation, embodies gestated to provide a new and efficacious mutually exclusive for erectile dysfunction (ED) patients that is essentially free of the troublesome incline consequences and cumbersome delivery methods which limit the use of other pharmacologic plannings.
Plastic vial(dedicated for peptide packing) or glass vial, quantity according to customer's detail requirement. Aviptadil, also known as vasoactive intestinal polypeptide (VIP), is a 28 amino acid neuropeptide that belongs to the glucagon-growth hormone-releasing factor secretion superfamily. It exerts potent anti-inflammatory and immunomodulatory effects.
In addition, Aviptadil acts as a potent systemic vasodilator and bronchodilator, it inhibits the proliferation of vascular and bronchial smooth muscle cells and decreases platelet aggregation. These biological effects are mediated by specific VIP receptors.
Size: 10 mg, Storage: A cool(2~8 ℃ ) & dry place protected from light, keep package close when not in use.
No comments:
Post a Comment